Hansa Biopharma AB (publ) (LON:0RC7)
London
· Delayed Price · Currency is GBP · Price in SEK 26.20
+0.60 (2.34%)
At close: May 9, 2025
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 136.22 million as of May 9, 2025. Its market cap has increased by 23.76% in one year.
Market Cap
136.22M
Enterprise Value
195.69M
Revenue
14.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.20
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 2.62M to 136.22M, an increase of 5,103.54%. That is a compound annual growth rate of 26.08%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 157.14B |
| GSK plc | 55.44B |
| Haleon | 35.99B |
| Smith & Nephew | 9.35B |
| ConvaTec Group | 5.24B |
| Hikma Pharmaceuticals | 4.46B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.37B |